Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-13.96%
operating margin TTM
-12.22%
revenue TTM
846.92 Million
revenue per share TTM
8.97$
valuation ratios | |
|---|---|
| pe ratio | -2.80 |
| peg ratio | -0.04 |
| price to book ratio | 1.04 |
| price to sales ratio | 0.39 |
| enterprise value multiple | -4.89 |
| price fair value | 1.04 |
profitability ratios | |
|---|---|
| gross profit margin | 68.83% |
| operating profit margin | -12.22% |
| pretax profit margin | -13.86% |
| net profit margin | -13.96% |
| return on assets | -17.62% |
| return on equity | -32.59% |
| return on capital employed | -19.4% |
liquidity ratios | |
|---|---|
| current ratio | 2.21 |
| quick ratio | 1.98 |
| cash ratio | 0.88 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 44.43 |
| operating cycle | 93.98 |
| days of payables outstanding | 44.14 |
| cash conversion cycle | 49.84 |
| receivables turnover | 7.37 |
| payables turnover | 8.27 |
| inventory turnover | 8.22 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.33 |
| debt equity ratio | 0.69 |
| long term debt to capitalization | 0.28 |
| total debt to capitalization | 0.41 |
| interest coverage | -6.01 |
| cash flow to debt ratio | 0.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.09 |
| cash per share | 1.22 |
| operating cash flow per share | 0.08 |
| free cash flow operating cash flow ratio | -1.12 |
| cash flow coverage ratios | 0.04 |
| short term coverage ratios | 1.05 |
| capital expenditure coverage ratio | 0.47 |
Frequently Asked Questions
When was the last time Myriad Genetics, Inc. (NASDAQ:MYGN) reported earnings?
Myriad Genetics, Inc. (MYGN) published its most recent earnings results on 31-07-2026.
What is Myriad Genetics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Myriad Genetics, Inc. (NASDAQ:MYGN)'s trailing twelve months ROE is -32.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Myriad Genetics, Inc. (MYGN) currently has a ROA of -17.62%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did MYGN's net profit margin stand at?
MYGN reported a profit margin of -13.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is MYGN's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.21 in the most recent quarter. The quick ratio stood at 1.98, with a Debt/Eq ratio of 0.69.